Chicago Equity Partners’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
$981K Sell
7,765
-3,270
-30% -$548K 0.1% 289
2019
Q4
$1.87M Sell
11,035
-1,980
-15% -$333K 0.11% 286
2019
Q3
$2.19M Buy
13,015
+10,505
+419% +$1.78M 0.1% 295
2019
Q2
$434K Buy
+2,510
New +$408K 0.02% 728
2015
Q4
– Sell
-4,895
Closed -$531K – 630
2015
Q3
$531K Buy
4,895
+570
+13% +$68.6K 0.01% 461
2015
Q2
$524K Buy
+4,325
New +$524K 0.01% 332

Other funds holding LH

Chicago Equity Partners's LH Position: Q1 2020 in Review

Chicago Equity Partners reduced its Labcorp (LH) stake by 30% in Q1 2020, selling an estimated $548K and leaving 7,765 shares worth $981K. The position accounts for 0.1% of the portfolio, ranked #289.

Chicago Equity Partners first reported a position in LH in Q2 2015 and has held it in 6 quarters since. The position peaked at $2.19M in Q3 2019. 760 funds tracked by Wall St. Rank hold LH as of Q1 2020.

  • Chicago Equity Partners held 7,765 shares of Labcorp worth $981K as of Q1 2020.
  • Chicago Equity Partners sold 3,270 Labcorp shares in Q1 2020, an estimated $548K.
  • Labcorp made up 0.1% of Chicago Equity Partners's portfolio in Q1 2020, its #289 holding.
  • Chicago Equity Partners first reported a position in Labcorp in Q2 2015 and has held it in 6 quarters since.
  • Chicago Equity Partners's Labcorp position peaked at $2.19M in Q3 2019.
  • 760 funds tracked by Wall St. Rank held Labcorp as of Q1 2020.

Based on Chicago Equity Partners's 13F filing for Q1 2020, filed 6 May 2020.